Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008
28th December 2009
American Cancer Society
Link,
DISEASE/CONDITION(S)
Colorectal cancer and adenomatous polyps
GUIDELINE CATEGORY
Prevention
Screening
CLINICAL SPECIALTY
Colon and Rectal Surgery
Family Practice
Gastroenterology
Geriatrics
Internal Medicine
Oncology
Preventive Medicine
Radiology
INTENDED USERS
Advanced Practice Nurses
Allied Health Personnel
Health Care Providers
Health Plans
Hospitals
Managed Care Organizations
Nurses
Patients
Physician Assistants
Physicians
Public Health Departments
GUIDELINE OBJECTIVE(S)
To provide a practical guideline for physicians to assist with informed decision making related to colorectal cancer (CRC) screening
To address a number of concerns about the complexity of offering multiple screening options and the degree to which the range of screening options and their performance, costs, and demands on individuals poses a significant challenge for shared decisions
In this update, the guideline developers have placed an emphasis on the value of preventing CRC, sought to address the importance of test sensitivity in the presence of low rates of programmatic screening, and attempted to provide improved guidance about test characteristics and quality issues to referring physicians.
American Cancer Society
Link,
DISEASE/CONDITION(S) Colorectal cancer and adenomatous polyps
GUIDELINE CATEGORY
Prevention
Screening
CLINICAL SPECIALTY
Colon and Rectal Surgery
Family Practice
Gastroenterology
Geriatrics
Internal Medicine
Oncology
Preventive Medicine
Radiology
INTENDED USERS
Advanced Practice Nurses
Allied Health Personnel
Health Care Providers
Health Plans
Hospitals
Managed Care Organizations
Nurses
Patients
Physician Assistants
Physicians
Public Health Departments
GUIDELINE OBJECTIVE(S)
To provide a practical guideline for physicians to assist with informed decision making related to colorectal cancer (CRC) screening
To address a number of concerns about the complexity of offering multiple screening options and the degree to which the range of screening options and their performance, costs, and demands on individuals poses a significant challenge for shared decisions
In this update, the guideline developers have placed an emphasis on the value of preventing CRC, sought to address the importance of test sensitivity in the presence of low rates of programmatic screening, and attempted to provide improved guidance about test characteristics and quality issues to referring physicians.
Keywords:
colorectal cancer, colorectal cancer screening, colorectal cancer symptoms, colorectal cancer treatment, metastatic colorectal cancer, adenomatous polyps, adenomatous polyps pathology, adenomatous colonic polyp, adenoma colon cancer,
colorectal cancer, colorectal cancer screening, colorectal cancer symptoms, colorectal cancer treatment, metastatic colorectal cancer, adenomatous polyps, adenomatous polyps pathology, adenomatous colonic polyp, adenoma colon cancer,
